ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

ClinicalTrials.gov ID: NCT04099888

Public ClinicalTrials.gov record NCT04099888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Randomised Open-Label Phase 2 Study to Assess the Safety, Tolerability and Efficacy of Fimaporfin-Induced Photochemical Internalisation of Gemcitabine Complemented by Gemcitabine/Cisplatin Chemotherapy Versus Gemcitabine/Cisplatin Alone in Patients With Inoperable Cholangiocarcinoma

Study identification

NCT ID
NCT04099888
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
PCI Biotech AS
Industry
Enrollment
41 participants

Conditions and interventions

Interventions

  • Fimaporfin and Gemcitabine Drug
  • Gemcitabine/Cisplatin chemotherapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 22, 2019
Primary completion
Apr 27, 2022
Completion
May 5, 2022
Last update posted
Sep 10, 2023

2019 – 2022

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010
Emory University Hospital, 1365C Clifton Road NE Atlanta Georgia 30322
University of Chicago Medical Center, 5841 South Maryland Avenue Chicago Illinois 60637
University of Louisville Louisville Kentucky 40202
The Mayo Clinic Hospital - Saint Mary's Campus, 1216 Second Street Southwest Rochester Minnesota 55902
Baylor College of Medicine Houston Texas 77096

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04099888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04099888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →